9 results
Causes of Diffuse and Localized Lymphadenopathy - Differential Diagnosis Algorithm
 • Reactive (Inflammatory / Infectious)
 •
Causes of Diffuse ... - Differential Diagnosis ... Algorithm • Reactive ... #Focal #Localized ... #Hematology #Oncology
Hair Loss (Alopecia) - General (Diffuse and Focal) Differential Diagnosis Algorithm

DIFFUSE
Scarring - Irreversible-biopsy required
 • Lupus
Diagnosis Algorithm ... contraceptives • Hyperthyroid ... #Alopecia #dermatology ... #Differential #Diagnosis ... #Algorithm #causes
Causes of Diffuse Lymphadenopathy - Differential Diagnosis Algorithm
Reactive:
 - Systemic Inflammatory
     •
Causes of Diffuse ... - Differential Diagnosis ... Algorithm Reactive ... Leukemia - History of Bleeding ... #Hematology #Oncology
THE LIMPING OR NON-WEIGHT BEARING CHILD PATHWAY

RED FLAGS - In all cases there are specific
markers which
Injury - Follow local ... cell disease Rheumatology ... #Limping #NWB #Algorithm ... #Child #Peds #Pediatrics ... #Diagnosis
Allopecia - Differential Diagnosis Framework for Hair Loss

Localized / Focal Hair Loss Pattern:
 • Scarring Alopecia:
- Differential Diagnosis ... Localized / Focal ... Traction alopecia Diffuse ... • Laboratory evaluation ... #Differential #Diagnosis
Diffuse Hair Loss (Alopecia) - Differential Diagnosis Algorithm

Scarring - Irreversible-biopsy required
 • Lupus erythematosus
 • Lichen
Diffuse Hair Loss ... - Differential Diagnosis ... Algorithm Scarring ... contraceptives • Hyperthyroid ... #Algorithm #causes
The 6 C’s of Primary Sclerosing Cholangitis (PSC)
PSC is a chronic, cholestatic, immune-mediated disease characterized by
ducts, commonly leading ... to multi-focal ... asymptomatic at diagnosis ... clinical trial evaluation ... #Cholangitis #diagnosis
Helpful Clinical Features in Evaluating Bleeding Disorders
Age of onset
 • Neonate - in 20% of haemophilias,
Clinical Features in Evaluating ... Bleeding Disorders ... haemophilias, bleeding ... History #peds #pediatrics ... #diagnosis #hematology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... median age at diagnosis ... an infection or bleeding ... #algorithm #hematology